Tilray Brands, Inc.
TLRY Healthcare Drug Manufacturers Specialty & Generic
Tilray Brands, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $915.5 million, up 11.5% from fiscal 2025. In the quarter to August 2026, revenue grew 22.7%, EPS was flat, free cash flow fell 36.6% and total debt rose 43.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow TLRY
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Aug '26 | May '26 | Feb '26 | Nov '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
221.39 | 234.63 | 264.82 | 291.55 |
+8 more quarters Free account |
Receivables |
190.62 | 189.17 | 118.37 | 109.07 | |
Inventory |
328.97 | 301.19 | 292.30 | 283.20 | |
Total current assets |
807.59 | 792.13 | 718.76 | 729.32 | |
Property, Plant, Equpment (Net) |
665.92 | 680.23 | 543.01 | 550.10 | |
Long-Term Investments |
7.09 | 7.23 | 8.25 | 14.22 | |
Goodwill and Intangible Assets (Total) |
794.82 | 795.13 | 775.69 | 774.09 | |
Long-term assets (Other) |
10.51 | 10.98 | 11.07 | 11.07 | |
Total non-current assets |
1,520.37 | 1,535.88 | 1,355.96 | 1,369.28 | |
Total Assets |
2,327.95 | 2,328.01 | 2,074.72 | 2,098.60 | |
Notes Payable |
8.69 | 8.78 | 8.83 | 8.57 | |
Accounts Payable |
335.42 | 318.09 | 224.00 | 226.42 | |
Current Part of Debt |
74.68 | 18.16 | 17.45 | 16.89 | |
Current Part of Capital Lease |
11.90 | 13.36 | 7.26 | 7.44 | |
Total current liabilities |
430.69 | 358.38 | 257.54 | 259.32 | |
Long Term Debt (Total) |
276.66 | 358.11 | 283.53 | 286.74 | |
Long Term Tax Liability (Deferred) |
9.75 | 12.26 | 7.88 | 5.62 | |
Non-current Liabilities (Other) |
4.19 | 4.40 | 0.16 | 0.42 | |
Total non-current liabilities |
290.59 | 374.77 | 291.57 | 292.78 | |
Total liabilities |
721.28 | 733.15 | 549.12 | 552.09 | |
Additional Paid In Capital |
6,674.47 | 6,627.06 | 6,520.50 | 6,511.48 | |
Common Stock (Net) |
0.15 | 0.13 | 0.12 | 0.12 | |
Retained Earnings |
(5,011.76) | (4,968.62) | (4,919.05) | (4,892.48) | |
Common Equity (Total) |
1,606.67 | 1,594.87 | 1,525.61 | 1,546.51 | |
Shareholders Equity (Total) |
1,606.67 | 1,594.87 | 1,525.61 | 1,546.51 | |
Shareholders Equity and Liabilities (Total) |
2,327.95 | 2,328.01 | 2,074.72 | 2,098.60 | |
Shares (Common) |
144.94 | 131.68 | 116.55 | 116.52 | |
Shareholders Equity (Tangible) |
811.86 | 799.74 | 749.91 | 772.42 | |
Net Debt |
129.95 | 141.64 | 36.17 | 12.07 | |
Total Debt |
351.34 | 376.27 | 300.99 | 303.63 |